Akorn, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1948-01-01
- Employees
- 2.2K
- Market Cap
- -
- Website
- http://www.akorn.com
Bioequivalence Study of Clindamycin Gel 1% in Treatment of Acne Vulgaris
- First Posted Date
- 2018-05-11
- Last Posted Date
- 2020-10-05
- Lead Sponsor
- Akorn, Inc.
- Target Recruit Count
- 1125
- Registration Number
- NCT03522441
- Locations
- 🇺🇸
Site 1, Brandon, Florida, United States
🇺🇸Site 11, Encino, California, United States
🇺🇸Site 4, Miramar, Florida, United States
Bioequivalence Study With Clinical Endpoint for Diclofenac Sodium Topical Gel 1%
Phase 3
Completed
- Conditions
- Osteoarthritis, Knee
- Interventions
- First Posted Date
- 2016-09-23
- Last Posted Date
- 2021-02-26
- Lead Sponsor
- Akorn, Inc.
- Target Recruit Count
- 934
- Registration Number
- NCT02913521
- Locations
- 🇪🇪
Medicum Ltd., Tallinn, Estonia
🇪🇪Dr.Monika Vask Ltd., Tartu, Estonia
🇪🇪Ltd. Elli Kahar, Tartu, Estonia
Bioequivalence Study for Benzyl Alcohol Lotion 5%.
Phase 3
Completed
- Conditions
- Head Lice
- Interventions
- First Posted Date
- 2015-12-09
- Last Posted Date
- 2021-01-27
- Lead Sponsor
- Akorn, Inc.
- Target Recruit Count
- 239
- Registration Number
- NCT02624843
- Locations
- 🇺🇸
Axis Clinical Trials, Los Angeles, California, United States
🇺🇸South Florida Family Health and Research Centers (Lice Source Services Inc), Plantation, Florida, United States
An Evaluation of the Onset and Duration of Action of AKF-1 Ophthalmic Solution in Treating Acute Allergic Conjunctivitis
- First Posted Date
- 2012-03-23
- Last Posted Date
- 2013-07-18
- Lead Sponsor
- Akorn, Inc.
- Target Recruit Count
- 90
- Registration Number
- NCT01561521
- Locations
- 🇺🇸
Andover Eye Associates, Andover, Massachusetts, United States
© Copyright 2025. All Rights Reserved by MedPath